{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"3.120","floor":"2.380"},"ipodate":{"start":"2010-09-16 00:00:00","end":"2010-09-21 00:00:00"},"minimumcapital":"3151.45","subscribed":"20.90","marketcap":"48.97億","H_marketcap":"--","pe":"25.14","codesrate":"50.00","link":"https://www1.hkexnews.hk/listedco/listconews/sehk/2010/0916/ltn20100916012_c.htm","ipopricing":"3.120","resultdate":"2010-09-28 00:00:00","enddate":"2010-09-21 00:00:00","listeddate":"2010-09-29 00:00:00","issuenumber":"42028.00萬","issuenumberhK":"12608.40萬","issuenumberother":"29419.60萬","grayprice":"--","sponsors":"瑞士信貸(香港)有限公司,摩根士丹利亞洲有限公司","raisemoney":"122270.00萬","use":"1、約35%或427.5百萬港元，將用于購買新的包裝設備與其他生產設備以及用于興建新生產設施的資本開支；\n2、約26%或320.9百萬港元，將用于在上海建立華東總部作為本集團區域中心；\n3、約7%或88.3百萬港元，將用于擴大及加強本集團現有經銷網絡及地方銷售團隊。\n4、約14%或176.5百萬港元，將用于設計、研究及開發新茶產品及改善本集團現有及備選產品；\n5、約7%或85.6百萬港元，將用于償還本集團所欠債務；\n6、約4%或53.0百萬港元，將用于升級ERP系統及整體信息系統；\n7、約6%或70.6百萬港元，將用于營運資金及其他一般公司用途以及日后收購互補業務。","shares":1000,"leadagent":"瑞士信貸(香港)有限公司,摩根士丹利亞洲有限公司","bookrunners":"瑞士信貸(香港)有限公司,摩根士丹利亞洲有限公司","coordinator":"瑞士信貸(香港)有限公司,摩根士丹利亞洲有限公司","firstDayOpen":"3.50","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"摩根士丹利亞洲有限公司","code":"E00926","name":"碧生源","fullname":"碧生源控股有限公司"},"institutioninfo":{"principaloffice":"香港九龍九龍灣宏照道33號國際交易中心20樓2005C-2006A室","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"趙一弘","secretary":"區立明","telephone":"(852) 2324 8000","substantialshareholders":"趙一弘及關連人士(51.05%),彭韙(7.86%)","principalactivities":"制造及銷售功能保健茶產品，以及減肥及其他藥品。","website":"http://www.besunyen.com"},"managerinfo":[],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":519}